|
Aug. 01, 2012 |
|
|
Dec. 17, 2018 |
|
|
jRCT2080221872 |
A Phase 2/3 Study of S-524101 in the Patients with Perennial Allergic Rhinitis |
|
| version: date: |
Shionogi & Co., Ltd. |
||
http://www.shionogi.co.jp/information/inquiry_entrance.html |
||
Interventional |
||
Multicenter, double-blind, parallel-group comparative study |
||
2-3 |
||
Patients who have a history of symptomatic allergic rhinitis for two or more years. |
||
Patients with allergic rhinitis, conjunctivitis or asthma due to other antigens which could confound accurate symptom assessment during study. |
||
| 12age old over | ||
| 64age old under | ||
Both |
||
Allergic rhinitis |
||
investigational material(s) |
||
Efficacy |
||
| SHIONOGI & CO., LTD. | |
| JapicCTI-121917 | |